SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-19-008149
Filing Date
2019-07-11
Accepted
2019-07-11 13:19:29
Documents
8

Document Format Files

Seq Description Document Type Size
1 AMENDED REGISTRATION STATEMENT gtbp_s1.htm S-1/A 1788543
2 CONSENTS OF EXPERTS AND COUNSEL gtbp_ex232.htm EX-23.2 1592
3 IMAGE gtbp_ex231000.jpg GRAPHIC 58257
4 IMAGE gtbp_im1.jpg GRAPHIC 16755
5 IMAGE gtbp_im2.jpg GRAPHIC 18288
6 IMAGE gtbp_im3.jpg GRAPHIC 34086
7 IMAGE gtbp_im4.jpg GRAPHIC 10787
8 IMAGE gtbp_im5.jpg GRAPHIC 19587
  Complete submission text file 0001654954-19-008149.txt   2009464
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-232261 | Film No.: 19950814
SIC: 2834 Pharmaceutical Preparations